Skip to content

Abnormal Anteroposterior Retina Thickness On Oct C6055313

Published: July 22, 2026Updated: August 20, 2026

An abnormal measurement of retinal thickness from an eye imaging scan. It may indicate retinal disease and often warrants closer monitoring or additional testing by an eye specialist.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
H53.9
ICD-11
9A00.0
Body system
ophthalmologic
Severity
mild
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Flashes of light

Brief bursts of light or lightning streaks in one or both eyes.

Seek immediate medical attention if you experience sudden flashes, as this may indicate retinal tearing or detachment.

!

Central scotoma

A blind spot or dark area in the center of your visual field.

Urgent ophthalmologic evaluation is required for any new central blind spot.

Blurred vision

(ophthalmologic)

Vision appears hazy or unfocused, making it difficult to see fine details clearly.

Frequency: 70-85% of patients

Decreased visual acuity

(ophthalmologic)

A reduction in the sharpness of vision, often measured as a decline in best-corrected visual acuity.

Frequency: 65-80% of patients

Metamorphopsia

(ophthalmologic)

Distorted vision where straight lines appear wavy or bent, often due to retinal swelling or irregularities.

Frequency: 40-60% of patients

Floaters

(ophthalmologic)

Small dark shapes or specks that drift across your field of vision.

Frequency: 30-50% of patients

Difficulty with night vision

(ophthalmologic)

Reduced ability to see in low-light conditions or darkness.

Frequency: 35-45% of patients

Eye discomfort

(ophthalmologic)

General feeling of discomfort, heaviness, or pressure in or around the eye.

Frequency: 15-30% of patients

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Behavioral and nutritional therapy

Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.

lifestyle
2

Regular OCT imaging surveillance

Serial optical coherence tomography scans to monitor retinal thickness changes over time and detect progression of any underlying pathology.

monitoring
3

Anti-VEGF therapy

Intravitreal injections of anti-vascular endothelial growth factor agents to reduce retinal edema and normalize thickness in cases associated with neovascularization or macular edema.

medication

Additional treatment options

Laser photocoagulation

Targeted laser treatment to address abnormal blood vessel growth or seal leaking vessels contributing to abnormal retinal thickness.

procedure

Vitrectomy

Surgical removal of the vitreous gel to address tractional components contributing to abnormal retinal morphology and thickness.

surgical

Systemic disease management

Optimizing control of underlying conditions such as diabetes, hypertension, or autoimmune disorders that may contribute to retinal thickness abnormalities.

lifestyle

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Abnormal Anteroposterior Retina Thickness On Oct C6055313?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

American Academy of Ophthalmology. Preferred Practice Pattern: Retina and Vitreous. Ophthalmology. 2023;130(1):P1-P70.

guideline2023View source →
2

Fujimoto J, Swanson E. The Development, Commercialization, and Impact of Optical Coherence Tomography. Invest Ophthalmol Vis Sci. 2016;57(9):OCT1-OCT9.

review2016View source →
3

Myung JS, Lee JY, Park TK, et al. Normative Database of Retinal Nerve Fiber Layer and Ganglion Cell-Inner Plexiform Layer Thickness in Korean Population. Invest Ophthalmol Vis Sci. 2019;60(5):1611-1620.

meta_analysis2019View source →
4

Ryan SJ, Sadda SR, Hinton DR, et al. Retina. 6th ed. Elsevier; 2023:245-312.

textbook2023
5

Staurenghi G, Sadda S, Chakravarthy U, et al. Proposed Lexicon for Anatomic Landmarks in Normal Posterior Segment Spectral-Domain Optical Coherence Tomography. Ophthalmology. 2014;121(8):1572-1578.

consensus2014View source →
6

Wong IY, Koizumi H, Lai WW. Enhanced Depth Imaging Optical Coherence Tomography in Age-Related Macular Degeneration. Ophthalmology. 2011;118(12):2389-2395.

clinical_trial2011View source →
7

Sakamoto A, Hangai M, Yoshida N. Spectral-Domain Optical Coherence Tomography in Retinal Diseases. Jpn J Ophthalmol. 2018;62(2):133-169.

review2018View source →
8

International Society for Imaging in the Eye (ISIE). Recommendations for OCT Imaging Quality Standards. Acta Ophthalmol. 2020;98(5):e561-e568.

position_statement2020View source →
9

Girard MJ, Tun TA, Husain R, et al. Mapping Retinal Thickness Measurements from Spectral-Domain Optical Coherence Tomography: A Systematic Review. Br J Ophthalmol. 2017;101(3):359-366.

meta_analysis2017View source →
10

European Society of Retina Specialists (EURETINA). Guidelines for Management of Retinal Diseases. Ophthalmologica. 2022;247(2):75-98.

guideline2022View source →

Medication Comparisons

Compare medications used to treat Abnormal Anteroposterior Retina Thickness On Oct C6055313. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy